Navigation Links
Alexandria Real Estate Equities, Inc. Announces Pricing of Public Follow-On Offering of 7,000,000 Shares of Common Stock
Date:3/19/2009

PASADENA, Calif., March 19 /PRNewswire-FirstCall/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) announced today the pricing of its follow-on public offering of 7,000,000 shares of common stock at a price of $38.25 per share, upsized from an originally sized offering of 4,500,000 shares. Merrill Lynch & Co., Citi and J.P. Morgan acted as joint book-running managers and Keefe, Bruyette & Woods and Scotia Capital acted as co-managers in connection with the public offering. Alexandria Real Estate Equities, Inc. has granted the underwriters a thirty day option to purchase up to 1,050,000 additional shares to cover over-allotments, if any. The offering is expected to close on March 24, 2009, subject to customary closing conditions.

The Company intends to use the net proceeds from this offering to reduce the outstanding balance on its unsecured line of credit. The Company currently anticipates that it will then borrow funds under its unsecured line of credit to pay down $25 million of the Company's senior secured term loan. The Company may then also borrow from time to time under its unsecured line of credit to provide funds for general working capital and other corporate purposes, including the repayment of debt and selective redevelopment and development of existing or new life science properties.

Alexandria Real Estate Equities, Inc., Landlord of Choice to the Life Science Industry(R), is a publicly-traded real estate investment trust focused principally on science-driven cluster formation through the ownership, operation, management and selective redevelopment, development and acquisition of properties containing technical environments, including office/laboratory space. Our properties are designed and improved for lease primarily to institutional (universities and independent not-for-profit institutions), pharm
'/>"/>

SOURCE Alexandria Real Estate Equities, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Alexandria Real Estate Equities, Inc. Reports Third Quarter 2007 Results
2. Alexandria Real Estate Equities, Inc. Features Green Buildings and Sustainable Operations Initiatives and Tour at 2008 BIO
3. Coherent Announces Restatement Related to Stock-Based Compensation
4. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
5. Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006
6. Unigene Restates Policy on Analyst Reports
7. Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate
8. Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates
9. Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate
10. Norton & Associates Inc. Adds $3bnUSD Commercial Real Estate Investment P & L Management Holding Group; US Property Portfolio Inc.
11. BioMed Realty Trust Announces New Financing for Joint Venture With Prudential Real Estate Investors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 20, 2014 Local veterinary surgeon, Dr. ... investigational study of donor stem cells for dogs with ... therapy and has performed clinical stem cell therapy for ... to determine if a single injection of donor stem ... help reduce pain and inflammation in the treated joints. ...
(Date:10/19/2014)... 2014 OCTOBER 20-22, 2014: ... ABIM will take place at the ... ABIM 2014 is now available at ... companies and organizations from all over the ... on the latest products and developments on ...
(Date:10/19/2014)... (PRWEB) October 19, 2014 The ... bromine market in Asia-Pacific with analysis and forecast ... the Asia Pacific Bromine Market report, to get ... also provides a glimpse of the segmentation in ... various tables and figures. , http://www.micromarketmonitor.com/market/asia-pacific-bromine-6741503144.html ...
(Date:10/19/2014)... The Asia-Pacific Speech Analytics market report defines and segments ... forecast of revenue. This market is estimated to grow ... 2019, at a Compound Annual Growth Rate (CAGR) of ... TOC of the Asia-Pacific Speech Analytics market report to ... also provides a glimpse of the segmentation in the ...
Breaking Biology Technology:Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 3The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 2The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 3The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 4
... NEW YORK, MUNICH, Germany and AMSTERDAM, Netherlands, ... Holding, B.V., the,pan-European specialty pharmaceutical company, today ... 10 million revenue interest acquisition financing,agreement to ... and,certain other markets, from Procter & Gamble ...
... Va., Aug. 20 Inc. magazine announced,its 27th annual ... country. Federal Information Technology (IT) services provider,MicroTech, ranks No. ... The 2008 Inc. 500 list measures revenue growth ... U.S.-based, privately held, independent -,no subsidiaries or divisions of ...
... Eli Lilly and,Company (NYSE: LLY ) today announced ... (Nasdaq: SGXP ), a San Diego-based,biotechnology company focused ... The completion of the deal followed today,s Special,Stockholders Meeting, ... of the merger agreement with Lilly. Under the agreement, ...
Cached Biology Technology:TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 2TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 3TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 4TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 5MicroTech Ranks No. 285 on Inc. Magazine's 2008 List of the 500 Fastest Growing Private Companies in America 2Lilly Announces Completion of SGX Acquisition 2
(Date:10/14/2014)... tumors scavenge and hoard copper that is an essential ... a fatal weakness. , Researchers at Duke Medicine ... by delivering a trove of copper along with a ... the mineral, leaving non-cancer cells healthy. , The combination ... other uses, could soon be tested in clinical trials ...
(Date:10/14/2014)... been millions of years since T. rex ... Ohio University scientists is breathing life back into dinosaurs ... snouts. The research has important implications for how dinosaurs ... enhance the sense of smell and cool their brains. ... University doctoral student Jason Bourke, lead author of the ...
(Date:10/14/2014)... One of the planet,s leading questions is how to ... increasingly variable climate. The Food and Agriculture Organization of ... 70% over the next 40 years to feed a ... of the necessary rise in food production. Plants—grains, ... by supporting livestock. Current research must tap into ...
Breaking Biology News(10 mins):Prostate cancer's penchant for copper may be a fatal flaw 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 3Building a bridge from basic botany to applied agriculture 2Building a bridge from basic botany to applied agriculture 3
... 2009 -- A new study conducted at Ben-Gurion University ... anti-inflammatory coxib medications may counter the positive effects of ... in the Proceedings of the National Academy of ... are taking aspirin and coxibs together are in fact ...
... structure of new anti-cancer agents has enabled a team of ... halting a common type of drug-resistant lung cancer. In ... of the journal Nature , the researchers report that ... drugs Iressa and Tarceva were stymied by a compound designed ...
... The journeys of two marine turtles around the world,s oceans ... a new research project launched by the University of Exeter. ... turtles that nest in Gabon, Western Central Africa. The research ... device, which enables the scientists to monitor their precise movements ...
Cached Biology News:Research yields new agent for some drug-resistant non-small cell lung cancers 2Research yields new agent for some drug-resistant non-small cell lung cancers 3Turtles' Christmas journey tracked by scientists 2
... Team The Schleicher & Schuell ... work center dedicated to custom protein ... facilitys experienced project teams, comprised of ... professionals, work closely with collaborators every ...
... Western blotting is a commonly used technique ... protein samples are electrophoresed on SDS-PAGE and ... or nylon, where they are probed with ... which allow reuse of Southern and Northern ...
... Peptide microarrays containing peptidomimetics built on ... on-chip synthesis platform. These microarrays are ... Custom Peptide Microarray Service. ... is completely customer specified. Thousands of ...
... time, you can identify and characterize high-value, ... interferences. The Agilent Multiple Affinity Removal System ... proteins from human serum, plasma, CSF samples ... With this revolutionary system, you can: ...
Biology Products: